• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后 30 天内的再入院情况。

Readmission in the 30 days after percutaneous coronary intervention.

机构信息

Department of Cardiology, Geisinger Medical Center, Danville, PA 17822, USA.

出版信息

JACC Cardiovasc Interv. 2013 Mar;6(3):237-44. doi: 10.1016/j.jcin.2012.10.015.

DOI:10.1016/j.jcin.2012.10.015
PMID:23517834
Abstract

OBJECTIVES

This study sought to identify the frequency and etiology of readmission within 30 days of percutaneous coronary intervention (PCI) in a large integrated healthcare system.

BACKGROUND

One-fifth of Medicare patients are readmitted within 30 days of hospitalization. Identifying the causes of readmission may help identify strategies to prevent readmission.

METHODS

All patients undergoing PCI (elective, urgent, and emergent) at our center between January 1, 2007, and April 12, 2010, were prospectively entered into the American College of Cardiology National Cardiovascular Data Registry. Patients readmitted to any hospital within 30 days of the index procedure were identified using an administrative database and telephone follow-up. Individual charts were reviewed independently by 2 investigators; disagreements regarding the cause for readmission were resolved by a third investigator.

RESULTS

During the study period, 3,255 PCI were performed, and 262 patients (8.0%) were readmitted within 30 days. Of these, 261 (99.6%) had medical records available for review. Reasons for readmission included: complications related to the PCI (n = 31, 11.9%); non-PCI cardiac causes related to index admission (n = 93, 35.6%); noncardiac causes related to index admission (n = 34, 13%); causes unrelated to the index admission (n = 103, 39.5%). Multivariable logistic regression modeling revealed that female sex, advanced age, peripheral arterial disease, prior valvular surgery, and PCI complications during the index procedure were associated with 30-day readmission.

CONCLUSIONS

Readmissions within 30 days due to complications related to PCI performed on index admission are rare (0.9% of all PCI) and are an infrequent cause of readmission (<12% of readmissions). Thirty-day readmission after PCI should not be used as a quality metric of PCI performance.

摘要

目的

本研究旨在确定在大型综合医疗保健系统中,经皮冠状动脉介入治疗(PCI)后 30 天内再入院的频率和病因。

背景

五分之一的 Medicare 患者在住院后 30 天内再次入院。确定再入院的原因可能有助于确定预防再入院的策略。

方法

2007 年 1 月 1 日至 2010 年 4 月 12 日期间,在我们中心接受 PCI(择期、紧急和紧急)的所有患者均前瞻性地纳入美国心脏病学会国家心血管数据注册中心。使用行政数据库和电话随访确定索引手术后 30 天内入住任何医院的患者。两名研究人员分别独立审查病历;对再入院原因的分歧由第三名研究人员解决。

结果

在研究期间,进行了 3255 次 PCI,262 例(8.0%)患者在 30 天内再入院。其中,261 例(99.6%)有病历可供审查。再入院的原因包括:与 PCI 相关的并发症(n=31,11.9%);与索引入院相关的非 PCI 心脏原因(n=93,35.6%);与索引入院相关的非心脏原因(n=34,13%);与索引入院无关的原因(n=103,39.5%)。多变量逻辑回归模型显示,女性、高龄、外周动脉疾病、既往瓣膜手术以及索引手术期间的 PCI 并发症与 30 天再入院相关。

结论

索引入院期间因 PCI 相关并发症导致的 30 天内再入院罕见(所有 PCI 的 0.9%),且是再入院的一个不常见原因(<12%的再入院)。PCI 后 30 天再入院不应作为 PCI 效果的质量指标。

相似文献

1
Readmission in the 30 days after percutaneous coronary intervention.经皮冠状动脉介入治疗后 30 天内的再入院情况。
JACC Cardiovasc Interv. 2013 Mar;6(3):237-44. doi: 10.1016/j.jcin.2012.10.015.
2
A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention.一种用于识别经皮冠状动脉介入治疗后30天再入院高风险患者的预测模型。
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):429-35. doi: 10.1161/CIRCOUTCOMES.111.000093. Epub 2013 Jul 2.
3
30-day readmission for patients undergoing percutaneous coronary interventions in New York state.纽约州行经皮冠状动脉介入治疗患者的 30 天再入院率。
JACC Cardiovasc Interv. 2011 Dec;4(12):1335-42. doi: 10.1016/j.jcin.2011.08.013.
4
Causes of short-term readmission after percutaneous coronary intervention.经皮冠状动脉介入治疗后短期再入院的原因。
Circ Cardiovasc Interv. 2014 Feb;7(1):97-103. doi: 10.1161/CIRCINTERVENTIONS.113.000988. Epub 2014 Jan 14.
5
Early readmissions after percutaneous coronary intervention in a rural tertiary care center (from the Guthrie Health Off-label Stent [GHOST] Registry).农村三级医疗中心经皮冠状动脉介入治疗后的早期再入院情况(来自格思里健康超适应证支架[GHOST]登记处)。
Am J Cardiol. 2012 Aug 15;110(4):491-7. doi: 10.1016/j.amjcard.2012.04.022. Epub 2012 May 11.
6
All-cause readmission and repeat revascularization after percutaneous coronary intervention.经皮冠状动脉介入治疗后的全因再入院和重复血运重建。
Cardiol J. 2012;19(2):174-9. doi: 10.5603/cj.2012.0030.
7
Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis.美国经皮冠状动脉介入治疗后的 30 天再入院率和费用:全国再入院数据库分析。
Circ Cardiovasc Interv. 2017 Dec;10(12). doi: 10.1161/CIRCINTERVENTIONS.117.005925.
8
All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients.一组医疗保险患者经皮冠状动脉介入治疗后的全因再入院和重复血运重建情况。
J Am Coll Cardiol. 2009 Sep 1;54(10):903-7. doi: 10.1016/j.jacc.2009.04.076.
9
Future of the PCI Readmission Metric.经皮冠状动脉介入治疗再入院指标的未来。
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):186-9. doi: 10.1161/CIRCOUTCOMES.115.002472. Epub 2016 Jan 26.
10
Thirty-day readmission rates after PCI in a metropolitan center in Europe: incidence and impact on prognosis.欧洲某大都市中心经皮冠状动脉介入治疗(PCI)后的30天再入院率:发生率及其对预后的影响。
J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):238-45. doi: 10.2459/JCM.0000000000000136.

引用本文的文献

1
Early vs. Late Readmission following Percutaneous Coronary Intervention: Predictors and Impact on Long-Term Outcomes.经皮冠状动脉介入治疗后早期与晚期再入院:预测因素及对长期结局的影响
J Clin Med. 2023 Feb 20;12(4):1684. doi: 10.3390/jcm12041684.
2
Incidence and prognosis of late readmission after percutaneous coronary intervention.经皮冠状动脉介入治疗后晚期再入院的发生率和预后。
Cardiol J. 2023;30(5):696-704. doi: 10.5603/CJ.a2022.0117. Epub 2022 Dec 13.
3
Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention.
糖尿病对经皮冠状动脉介入治疗后长期全因再住院的影响。
Diab Vasc Dis Res. 2022 Jul-Aug;19(4):14791641221113788. doi: 10.1177/14791641221113788.
4
Factors affecting hospital readmission rates following an acute coronary syndrome: A systematic review.影响急性冠状动脉综合征患者出院后再入院率的因素:系统评价。
J Clin Nurs. 2022 Sep;31(17-18):2377-2397. doi: 10.1111/jocn.16122. Epub 2021 Nov 22.
5
Temporal Trends and Patient Characteristics Associated with 30-Day Hospital Readmission Rates after a First Acute Myocardial Infarction.首次急性心肌梗死 30 天后住院再入院率的时间趋势及相关患者特征。
Am J Med. 2021 Sep;134(9):1127-1134. doi: 10.1016/j.amjmed.2021.03.024. Epub 2021 Apr 20.
6
Incidence and Predictors of Unplanned Hospital Readmission after Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后计划外再次入院的发生率及预测因素
J Clin Med. 2020 Oct 10;9(10):3242. doi: 10.3390/jcm9103242.
7
Associations Between Hospital Length of Stay, 30-Day Readmission, and Costs in ST-Segment-Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis.ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后住院时间、30 天再入院率与费用的相关性:一项全国再入院数据库分析。
J Am Heart Assoc. 2020 Jun 2;9(11):e015503. doi: 10.1161/JAHA.119.015503. Epub 2020 May 29.
8
The prevalence of 30-day readmission after acute myocardial infarction: A systematic review and meta-analysis.急性心肌梗死后 30 天再入院率:系统评价和荟萃分析。
Clin Cardiol. 2019 Oct;42(10):889-898. doi: 10.1002/clc.23238. Epub 2019 Aug 12.
9
Should We Care About Short-Term Readmissions After Percutaneous Coronary Intervention?经皮冠状动脉介入治疗后我们应该关注短期再入院情况吗?
Circ Cardiovasc Interv. 2017 Dec;10(12). doi: 10.1161/CIRCINTERVENTIONS.117.006123.
10
Beyond discrimination: A comparison of calibration methods and clinical usefulness of predictive models of readmission risk.超越歧视:再入院风险预测模型的校准方法和临床实用性比较。
J Biomed Inform. 2017 Dec;76:9-18. doi: 10.1016/j.jbi.2017.10.008. Epub 2017 Oct 24.